About: NanOlogy
Profile:
Posts by NanOlogy:
- NanOlogy to Present Positive Preclinical Data for NanoDoce® in Treatment of Uro-Oncologic Cancers at 2019 Genitourinary Cancers (ASCO-GU) Symposium (February 13, 2019 - NanOlogy Press Release)
- NanOlogy Chief Medical Officer on Panel to Discuss Next Wave of Innovation in IO Therapy at BIO CEO & Investor Conference (February 5, 2019 - NanOlogy Press Release)
- SABCS 2018 Poster: Phase 1/2 Study of Topical SOR007 for Cutaneous Metastases (January 15, 2019 - Publications)
- NanOlogy Named to BioSpace Top 20 Life Science Startups to Watch in 2019 (January 11, 2019 - Home Page, NanOlogy in the News)
- Feb 11-12 2019 : BIO CEO & Investor Conference, New York (January 11, 2019 - NanOlogy Events)
- Feb 14-16 2019 : ASCO Genitourinary Cancers Symposium, San Francisco (January 11, 2019 - NanOlogy Events)
- Apr 11 2019 : 4th Annual Drug Development Networking Summit, Bridgewater, NJ (December 29, 2018 - NanOlogy Events)
- May 17-22 2019 : American Thoracic Society 2019 Conference, Dallas (December 28, 2018 - NanOlogy Events)
- Wuxi AppTec: Small Molecule Chemotherapy May Play a Big Role in Cancer Immunotherapy (November 6, 2018 - Home Page, NanOlogy in the News)
- Positive Preclinical Findings from Inhaled NanoPac® Lung Study Published in the Journal of Aerosol Medicine and Pulmonary Drug Delivery (October 30, 2018 - NanOlogy Press Release)
- Journal of Aerosol Medicine and Pulmonary Drug Delivery: Pharmacokinetic Profile of Inhaled Submicron Particle Paclitaxel (NanoPac®) in a Rodent Model (October 29, 2018 - Publications)
- DFB Soria Completes a Phase 2 Clinical Trial of Submicron Particle Paclitaxel Anhydrous Ointment for Actinic Keratosis (September 18, 2018 - NanOlogy Press Release, Soria)
- DFB Soria Completes a Phase 2 Clinical Trial of Submicron Particle Paclitaxel Anhydrous Ointment for Actinic Keratosis (September 18, 2018 - Uncategorized)
- Drug Development: Targeted Delivery of Submicron Particle Cancer Chemotherapy: Helping Shift the Immunotherapy Paradigm (August 29, 2018 - NanOlogy in the News)
- NanOlogy Adds Clinical Trial Sites for Phase 2 Clinical Trials of NanoPac® in Pancreatic Cancer and Pancreatic Mucinous Cysts (August 8, 2018 - NanOlogy Press Release)
- ASCO 2018 Poster: NanoPac Inhalation Treatment of NSCLC in a Nude Rat Orthotopic Lung Cancer Model (June 4, 2018 - Publications)
- Drug Delivery: NanOlogy Touts Preclinical Data for Inhaled NanoPac Cancer Drug (May 30, 2018 - NanOlogy in the News)
- NanOlogy to Unveil Positive Preclinical Data for Inhaled NanoPac® in Treatment of Lung Cancer at 2018 ASCO Annual Meeting (May 29, 2018 - NanOlogy Press Release)
